BioLife Solutions Inc (BLFS)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	52,557	74,386	95,192	103,106	106,723	144,095	126,844	193,158	189,347	145,904	143,561	66,469	56,290	32,105	25,891	23,311	24,721	38,922	34,012	29,193
Payables	US$ in thousands	3,573	3,838	4,213	4,984	2,270	11,980	10,686	15,525	15,367	13,140	11,537	11,711	14,945	14,296	9,847	4,276	3,672	2,355	3,077	3,522
Payables turnover		14.71	19.38	22.59	20.69	47.01	12.03	11.87	12.44	12.32	11.10	12.44	5.68	3.77	2.25	2.63	5.45	6.73	16.53	11.05	8.29

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $52,557K ÷ $3,573K
= 14.71

BioLife Solutions Inc's payables turnover has fluctuated over the years, ranging from a low of 2.25 in September 2021 to a high of 47.01 in December 2023. This ratio measures how efficiently the company is managing its accounts payable by evaluating how many times in a year the company pays off its suppliers on average.

A higher payables turnover ratio indicates that the company is paying off its suppliers more frequently, which could be a sign of good financial health and strong liquidity. Conversely, a lower ratio may suggest that the company is taking longer to pay its suppliers, potentially straining relationships or indicating cash flow issues.

In the latest period of December 31, 2024, the payables turnover ratio stands at 14.71, which indicates that BioLife Solutions Inc is managing its payables more efficiently compared to previous periods. This improvement may be due to better cash management practices or changes in supplier relationships.

Overall, analyzing the payables turnover ratio provides valuable insights into how effectively BioLife Solutions Inc is managing its accounts payable and its relationships with suppliers. It is essential for stakeholders and investors to monitor this trend to assess the company's financial health and operational efficiency.